CClinicalTrials.gg
CompletedNCT01322945BNIUpdated Dec 10, 2013Results posted

Barrow Nasal Inventory Survey

An observational study in Pituitary Tumors, sponsored by St. Joseph's Hospital and Medical Center, Phoenix. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-12-10.

Sponsored by St. Joseph's Hospital and Medical Center, Phoenix · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
94
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate patient nasal outcome following endo-nasal surgery. This type of surgery is conducted for pituitary and skull base tumors. There is no published data on trauma to the nose during surgery and how it impacts nasal functioning. The investigators propose to develop a survey and administer it to patients before and after surgery to learn about their perception of nasal functioning.

Read the detailed description

A 9-item patient survey (the ASK Nasal Inventory) focusing on the most common postoperative complaints, such as crusting, sinusitis, pain, and ease of breathing, was developed by the anterior skull base team at the Barrow Neurological Institute. Content was validated in structured patient interviews by four subject-matter experts with both endonasal and control groups. Eligible patients for the control group included patients undergoing any neurosurgical procedure requiring anesthesia that did not involve the endonasal corridor, such as spinal decompression procedures, craniotomies for trigeminal neuralgia, and shunting procedures. This survey was self-administered pre- and 3 months post-surgery.

02

Conditions studied

  • Pituitary Tumors

Browse trials for

03

In context

Pituitary Neoplasms

175 studies on the registry are indexed under Pituitary Neoplasms; 48 are open to participants now.

This study's enrollment of 94 is below the median of 150 across 71 observational studies indexed under Pituitary Neoplasms.

Browse Pituitary Neoplasms studies →

Lead sponsor

St. Joseph's Hospital and Medical Center, Phoenix is the lead sponsor of 63 studies on the registry; 11 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Neurosurgery and endocrinology clinic

Inclusion criteria

  • Adults with planned endonasal surgery for pituitary tumor or skull base lesion

Exclusion criteria

Exclusion Criteria:

  • Children
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
94 participants (actual)
Patient registry
No

Groups and cohorts

  • Endonasal surgery

    Single cohort of patients undergoing endonasal surgery

06

What researchers measure

Primary outcomes

  1. Change in Mean Survey Response From Baseline to 90 Days Post Surgery

    Mean survey response at 90 days post surgery between the control patients and the endonasal surgery patients using the Anterior skull base nasal inventory (ASK Nasal Inventory. A 5-point Likert scale for each question on the ASK Nasal inventory measures frequency of nasal symptoms where 1=never, 2= a little of the time, 3=some of the time, 4=most of the time, 5= all of the time. Total mean Likert scores were compared in the endonasal group to the control group after surgery. Scores range from minimum of 9 to maximum of 45. The lower the score the fewer the nasal complaints.

    Time frame: Baseline, 90 days post surgery

Secondary outcomes

  1. Test-retest Reliability of the ASK Nasal Inventory

    First 12 endonasal and 10 control patients enrolled in the study completed the ASK Nasal Inventory at 90 days and 120 days post surgery to measure reliablity of the survey (they scored the 9-item instrument similarly at both time frames)comparing 5-point Likert scale scores. Pearson correlation was used to determine a correlation between each patient's responses at 90 days post op and 120 days post op.

    Time frame: 90 days and 120 days post surgery

07

Results

Posted Dec 10, 2013

Participant flow

Eligible adult patients were identified in the outpatient neurosurgical clinics at the Barrow Neurological Institute between October 2010 and June 2011.

Participant flow — Overall Study
MilestoneEndonasal GroupControl Group
Started5242
Completed5242
Not completed00

Outcome measures

PrimaryChange in Mean Survey Response From Baseline to 90 Days Post Surgery

Mean survey response at 90 days post surgery between the control patients and the endonasal surgery patients using the Anterior skull base nasal inventory (ASK Nasal Inventory. A 5-point Likert scale for each question on the ASK Nasal inventory measures frequency of nasal symptoms where 1=never, 2= a little of the time, 3=some of the time, 4=most of the time, 5= all of the time. Total mean Likert scores were compared in the endonasal group to the control group after surgery. Scores range from minimum of 9 to maximum of 45. The lower the score the fewer the nasal complaints.

Time frame:
Baseline, 90 days post surgery
Reported as:
Mean · units on a scale
Change in Mean Survey Response From Baseline to 90 Days Post Surgery
units on a scaleEndonasal GroupControl Group
Change in Mean Survey Response From Baseline to 90 Days Post Surgery17.3 ± 6.713.5 ± 4.2
Statistical analysis
  • Endonasal Group vs Control Group · t-test, 2 sided · p = 0.001
SecondaryTest-retest Reliability of the ASK Nasal Inventory

First 12 endonasal and 10 control patients enrolled in the study completed the ASK Nasal Inventory at 90 days and 120 days post surgery to measure reliablity of the survey (they scored the 9-item instrument similarly at both time frames)comparing 5-point Likert scale scores. Pearson correlation was used to determine a correlation between each patient's responses at 90 days post op and 120 days post op.

Time frame:
90 days and 120 days post surgery
Reported as:
Number · Correlation Coefficient
Test-retest Reliability of the ASK Nasal Inventory
Correlation CoefficientEndonasal GroupControl Group
Test-retest Reliability of the ASK Nasal Inventory0.870.95

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Endonasal Group—0/52 (0%)0/52 (0%)
Control Group—0/42 (0%)0/42 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Endonasal GroupControl GroupTotal
<=18 years000
Between 18 and 65 years413273
>=65 years111021
Age, Continuous
Age, Continuous(years)Endonasal GroupControl GroupTotal
Mean50 ± 15.4954.17 ± 14.8350.27 ± 15.26
Sex: Female, Male
Sex: Female, Male(Participants)Endonasal GroupControl GroupTotal
Female252449
Male271845
Region of Enrollment
Region of Enrollment(participants)Endonasal GroupControl GroupTotal
United States524294
08

Study locations

1 site
  • Barrow Neurological Institute
    Phoenix, Arizona 85013, United States
09

References and documents

Publications

  • Little AS, Jahnke H, Nakaji P, Milligan J, Chapple K, White WL. The anterior skull base nasal inventory (ASK nasal inventory): a clinical tool for evaluating rhinological outcomes after endonasal surgery for pituitary and cranial base lesions. Pituitary. 2012 Dec;15(4):513-7. doi: 10.1007/s11102-011-0358-4. PubMed 22038032 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01322945
Lead sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Responsible party
Sponsor
First posted
Mar 25, 2011
Start date
Oct 2010
Primary completion
Jun 2011
Completion
Jun 2011
Results posted
Dec 10, 2013
Last update
Dec 10, 2013

Study contacts

Andrew Little, MD
principal investigator · Barrow Neurological Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion